Professor and Jack L. Beal Chair; Editor, Journal of Natural Products
Dr. A. Douglas Kinghorn has been Professor and Jack L. Beal Chair in Natural Products Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University since 2004. He received doctoral degrees from the University of London [Ph.D. in Pharmacognosy, 1975; D.Sc. in Pharmacy, 1990]. Dr. Kinghorn performed postdoctoral work at the University of Mississippi and the University of Illinois at Chicago. His research interests are on the isolation, characterization, and biological evaluation of natural products from higher plants, particularly with potential anticancer, anti-infective, and taste-modifying activities.
Dr. Kinghorn is a Fellow of five scientific and professional societies and of The School of Pharmacy, University College London (UCL). Dr. Kinghorn was designated as the 1993 B. Kenneth West University Scholar (Senior University Scholar) by the University of Illinois Foundation and was awarded the 2002-2003 University of Illinois at Chicago Award for Excellence in Teaching. He received the 2010 Norman R. Farnsworth Research Achievement Award of the American Society of Pharmacognosy for lifetime contributions to natural products research. In December 2011, he was awarded an Honorary Doctor of Science degree from the University of Bradford in the United Kingdom. He has authored or co-authored about 475 peer-reviewed research articles, review articles, and book chapters. Dr. Kinghorn has been Major and/or Thesis Advisor/Committee Member Chair to ca. 45 graduate students and has supervised over 60 postdoctorals and visiting scholars.
R&D Director, System Integration, Becton Dickinson and Company, Diagnostic Systems
Adam earned a B.S. in Mathematics and Chemistry from Gettysburg College and holds a Ph.D. in Analytical Chemistry from the University of Maryland, College Park. Adam was a National Science Foundation post-doctoral fellow at the National Institute of Standards and Technology in Gaithersburg, MD for two years. He then moved to industry as a Scientist with Gene Logic working in the field of DNA microarrays. Adam moved into technical management with MetriGenix, as a spin-out of Gene Logic, as the Director of Product Development and eventually the Vice President for Research and Development. In 2005, Adam joined Becton Dickinson and Company in the Diabetes Care business unit developing continuous glucose monitoring products. He transitioned to the Diagnostics Systems business unit in 2007 as the leader for System Engineering department which is his current role. Adam has been a member of the ACS since his undergraduate studies at Gettysburg College.
Adrian’s background in the pharmaceutical and agrochemical industries gives him an in-depth understanding of his clients’ business goals. This enables him to provide them with focused, commercially minded advice in the areas of patents, designs and supplementary protection certificates.
Adrian works closely with Fraser Brown, Nick Bennett and Hazel Stewart to advise clients, particularly in the life sciences. Adrian develops close and long standing relationships with domestic clients, multinational corporations and overseas attorneys, who like his direct and collaborative approach.
Adrian has a particular expertise in post-grant issues in the pharmaceutical industry, which has been used to the particular advantage of clients based outside Europe, who rely on Adrian to help develop and implement their European strategies. Adrian also enjoys representing clients in oral proceedings at the EPO. Adrian Bradley – energising ideas for Cleveland clients since 2007
Editor-in-Chief, Organic Letters
Amos B. Smith, III, is the Rhodes-Thompson Professor of Chemistry as well as Member of the Monell Chemical Senses Center and Associate Director of the Penn Center for Molecular Discovery at the University of Pennsylvania. In addition, he is both an Honorary Member and Visiting Director of the Kitasato Institute in Tokyo. Dr. Smith's research is dedicated to natural product synthesis, bioorganic chemistry, and materials science. More than 75 architecturally complex natural products have been prepared in his laboratory. Moreover, Dr. Smith, in collaboration with Ralph Hirschmann, pioneered the design and synthesis of non-peptide peptidomimetics of neuropeptideic hormone/transmitters and protease enzyme inhibitors. In collaboration with Peter Jurs, Dr. Smith developed groundbreaking computerized pattern recognition techniques that make it possible to analyze primate chemical communication.
Dr. Smith received his PhD from Rockefeller University. To date, he has co-authored over 575 publications and delivered over 600 invited lectures, including plenary lectures at the National Organic Chemistry Symposium and numerous Gordon Research Conferences. His recent honors and awards include Honorary Membership in the Pharmaceutical Society of Japan, Fellow of the American Association for the Advancement of Science, Royal Society of Chemistry Centenary Medal, Yamada Prize, Fellow of the American Academy of the Arts and Sciences, and Inaugural Fellow of the American Chemical Society.Kolkata, India
ACS Publications Division, Manager, Peer Review Operations
Anne Coghill is employed by the American Chemical Society Publications Division. As Manager, Peer Review Operations, Anne and her colleagues work with over 375 editorial offices worldwide responsible for managing the peer review process for ACS’s journals. In her tenure with ACS, Anne has worked in both the journal and book publishing programs. She has a bachelor of science in chemistry from Illinois State University and a master’s in management from Northwestern University. Anne is also the co-editor of The ACS Style Guide, third edition. She lives in central Illinois with her family, and when not working, Anne is an enthusiastic golfer.
ACS Immediate Past President
Bassam Z. Shakhashiri is the first holder of the William T. Evjue Distinguished Chair for the Wisconsin Idea at UW-Madison. He is well known internationally for his effective leadership in promoting excellence in science education at all levels, and for his development and use of demonstrations in the teaching of chemistry in classrooms as well as in less formal settings, such as museums, convention centers, shopping malls and retirement homes. The Encyclopedia Britannica sites him as the "dean of lecture demonstrators in America." His scholarly publications, including the multi-volume series, Chemical Demonstrations: A Handbook for Teachers of Chemistry, are models of learning and instruction that have been translated into several languages. He is an advocate for policies to advance knowledge and to use science and technology to serve society. He promotes the exploration and establishment of links between science, the arts and the humanities, and the elevation of discourse on significant societal issues related to science, religion, politics, the economy, and ethics. Professor Shakhashiri was the 2011 President-Elect of the American Chemical Society, is serving a one-year term as president in 2012 and will be immediate past president in 2013.
Bradley Miller, Director, Office of International Activities, American Chemical Society
Dr. Miller has worked for ACS since 1999 developing programs, products, and services to advance chemical sciences through collaborations in Africa, Asia, Europe, Latin America and the Middle East. At ACS he works with committees, technical divisions, local sections and members to create opportunities for chemistry to address global challenges through in-person and web-based scientific network development, research collaborations, and educational exchange. Miller serves on the US National Commission for UNESCO and in 2009 was appointed to co-chair the ACS 2011 International Year of Chemistry Staff Working Group. His team leadership resulted in receiving the ACS Catalyst Award for ACS’ contributions to global and domestic IYC celebrations.
In 2006 Miller was recipient of an NSF Discovery Corps Fellowship fostering US/Brazil collaboration in chemistry of biomass conversions to biofuels. He has worked for university-based international programs, for a higher education association focused on principles of quality assurance for transnational education, and for a private voluntary organization dedicated to international allied health sciences.
Dr. Miller has obtained a Ph.D. from the University of Arizona, a master's degree from the University of Northern Colorado and a baccalaureate degree from University of Virginia - Wise. He speaks French, Spanish and Portuguese and has published nine articles and book chapters and is a frequent invited speaker on topics related to international aspects of non-profit S&T association management, and scientific, professional and academic mobility.
President, ACS Publications Division
Dr. Crawford received a B.S. with High Honors in Chemistry from the University of Maryland, and a Ph.D. in Biochemical and Biophysical Sciences from the Johns Hopkins University, followed by postdoctoral research at Los Alamos National Laboratory and university teaching. After two decades in the commercial STM publishing industry, including senior executive positions with John Wiley & Sons, he joined ACS in 2004 and was appointed President of the Publications Division in 2007. He holds general management responsibility for ACS’ portfolio of 44 peer-reviewed journals and the operations of Chemical & Engineering News.
Professor of Medicinal Chemistry and Associate Editor, the Journal of Medicinal Chemistry
Dr. Brian Blagg is a Professor of Medicinal Chemistry at The University of Kansas. He received Bachelor degrees in Chemistry and in Environmental Studies from Sonoma State University in 1994. In 1999, he received his Ph.D. in Organic Chemistry under the guidance of C. Dale Poulter (Editor-in-Chief of the Journal of Organic Chemistry). In 2002, he completed his postdoctoral work under the supervision of Dale Boger (Editor-in-Chief of Bioorganic and Medicinal Chemistry Letters), and became an Assistant Professor at The University of Kansas. In 2007, he was promoted with tenure to Associate Professor, and in 2010 to Professor. His research interests have focused on understanding and modulating protein folding processes that contribute to or lead to diseases such as cancer, Alzheimer’s, Parkinson’s, and other neuropathies. As a result of these efforts, the Blagg Research Group has been awarded several awards, the most notable of which was the 2009 American Chemical Society’s David W. Robertson Award for Excellence in Medicinal Chemistry.
Dr. Blagg has been heavily involved in scientific writing and the editorial review process. He has published more than 110 peer-reviewed manuscripts thus far. He currently serves as an Associate Editor for the Journal of Medicinal Chemistry and holds appointments as an editorial board member for Bioorganic and Medicinal Chemistry Letters, Bioorganic and Medicinal Chemistry, ACS Medicinal Chemistry Letter, Future Medicinal Chemistry, and Perspective in Medicinal Chemistry.